These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

347 related items for PubMed ID: 22138074

  • 1. Prodrug approaches to reduce hyperexcitation in the CNS.
    Vytla D, Combs-Bachmann RE, Hussey AM, McCarron ST, McCarthy DS, Chambers JJ.
    Adv Drug Deliv Rev; 2012 May 15; 64(7):666-85. PubMed ID: 22138074
    [Abstract] [Full Text] [Related]

  • 2. Delivery of therapeutics to the central nervous system.
    Chambers JJ.
    Adv Drug Deliv Rev; 2012 May 15; 64(7):589. PubMed ID: 22388004
    [No Abstract] [Full Text] [Related]

  • 3. Intranasal delivery of biologics to the central nervous system.
    Lochhead JJ, Thorne RG.
    Adv Drug Deliv Rev; 2012 May 15; 64(7):614-28. PubMed ID: 22119441
    [Abstract] [Full Text] [Related]

  • 4. Delivery of therapeutic agents to the central nervous system: the problems and the possibilities.
    Begley DJ.
    Pharmacol Ther; 2004 Oct 15; 104(1):29-45. PubMed ID: 15500907
    [Abstract] [Full Text] [Related]

  • 5. Modern methods for delivery of drugs across the blood-brain barrier.
    Chen Y, Liu L.
    Adv Drug Deliv Rev; 2012 May 15; 64(7):640-65. PubMed ID: 22154620
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Prodrug approaches for CNS delivery.
    Rautio J, Laine K, Gynther M, Savolainen J.
    AAPS J; 2008 May 15; 10(1):92-102. PubMed ID: 18446509
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Nanotechnological advances for the delivery of CNS therapeutics.
    Wong HL, Wu XY, Bendayan R.
    Adv Drug Deliv Rev; 2012 May 15; 64(7):686-700. PubMed ID: 22100125
    [Abstract] [Full Text] [Related]

  • 11. Strategies for drug delivery to the central nervous system by systemic route.
    Kasinathan N, Jagani HV, Alex AT, Volety SM, Rao JV.
    Drug Deliv; 2015 May 15; 22(3):243-57. PubMed ID: 24471801
    [Abstract] [Full Text] [Related]

  • 12. CNS disorders--current treatment options and the prospects for advanced therapies.
    DiNunzio JC, Williams RO.
    Drug Dev Ind Pharm; 2008 Nov 15; 34(11):1141-67. PubMed ID: 18720140
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Nanomaterial-mediated CNS delivery of diagnostic and therapeutic agents.
    Biddlestone-Thorpe L, Marchi N, Guo K, Ghosh C, Janigro D, Valerie K, Yang H.
    Adv Drug Deliv Rev; 2012 May 15; 64(7):605-13. PubMed ID: 22178615
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Prodrug approaches for enhancing the bioavailability of drugs with low solubility.
    Müller CE.
    Chem Biodivers; 2009 Nov 15; 6(11):2071-83. PubMed ID: 19937841
    [Abstract] [Full Text] [Related]

  • 17. Applications of nanotechnology in drug delivery to the central nervous system.
    Saeedi M, Eslamifar M, Khezri K, Dizaj SM.
    Biomed Pharmacother; 2019 Mar 15; 111():666-675. PubMed ID: 30611991
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Medicinal chemistry based approaches and nanotechnology-based systems to improve CNS drug targeting and delivery.
    Vlieghe P, Khrestchatisky M.
    Med Res Rev; 2013 May 15; 33(3):457-516. PubMed ID: 22434495
    [Abstract] [Full Text] [Related]

  • 20. CNS drug delivery systems: novel approaches.
    Pathan SA, Iqbal Z, Zaidi SM, Talegaonkar S, Vohra D, Jain GK, Azeem A, Jain N, Lalani JR, Khar RK, Ahmad FJ.
    Recent Pat Drug Deliv Formul; 2009 Jan 15; 3(1):71-89. PubMed ID: 19149731
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.